Rizatriptan (Maxalt®) is a triptandrug developed by Merck & Co. for the treatment of migraineheadaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets.
{Almotriptan}
{Eletriptan}
{Frovatriptan}
{Naratriptan}
{Sumatriptan}
{Rizatriptan}
{Wikiproject on Drugs, which is an attempt to facilitate the categorization and creation of accurate and formal drug-related articles on BambooWeb. If you are interested in editing this article, please see its talk page and ensure your edits are consistent with the goals of the project.
